Australian clinical feasibility considerations for treatment of PTSD with cannabinoid-augmented exposure therapy.

Authors :: Ney LJ
Akosile W
Davey CG
Pitcher L
Felmingham K
Mayo L
Hill M
Strodl E
Source :: The Australian and New Zealand journal of psychiatry [Aust N Z J Psychiatry] 2024 Mar; Vol. 58 (3), pp. 198-200. Date of Electronic Publication: 2023 Dec 07.
Publication Year :: 2024
Abstract: Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: M.N.H. consults for Lundbeck Pharmaceuticals and Jazz Pharmaceuticals. None of the other authors have any conflicts of interest to declare.

Subjects :: Humans
Feasibility Studies
Australia
Treatment Outcome
Cannabinoids therapeutic use
Stress Disorders, Post-Traumatic drug therapy
Implosive Therapy

Full Text Access

Tools